Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience

Petrioli Roberto; Francini Edoardo; Roviello Franco; Marrelli Daniele; Fiaschi Anna Ida; Laera Letizia; Rossi Giulia; Bianco V.; Brozzetti S.; Roviello Giandomenico

首页> 外文期刊>Cancer chemotherapy and pharmacology. >Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience

【24h】

Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience

机译：晚期胃癌或胃食管癌患者先后使用表柔比星，奥沙利铂和5FU（EOF），多西他赛，奥沙利铂和5FU（DOF）顺序治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this study was to evaluate the activity and safety of epirubicin (EPI), oxaliplatin (l-OHP) and 5fluorouracil (5FU) (EOF) followed by docetaxel (D), l-OHP and 5FU (DOF) in patients with advanced gastric or gastroesophageal junction (GEJ) cancer.

机译：这项研究的目的是评估表柔比星（EPI），奥沙利铂（1-OHP）和5氟尿嘧啶（5FU）（EOF）以及多西他赛（D），1-OHP和5FU（DOF）的活性和安全性晚期胃或胃食管交界处（GEJ）癌症。

著录项

来源
《Cancer chemotherapy and pharmacology.》 |2015年第5期|共7页
作者
Petrioli Roberto; Francini Edoardo; Roviello Franco; Marrelli Daniele; Fiaschi Anna Ida; Laera Letizia; Rossi Giulia; Bianco V.; Brozzetti S.; Roviello Giandomenico;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Gastric cancer; Oxaliplatin; Docetaxel; Fluorouracil; Sequential chemotherapy; Gastroesophageal cancer;

机译：胃癌;奥沙利铂;多西他赛;氟尿嘧啶;序贯化疗;胃食管癌;

相似文献

外文文献
中文文献
专利

1. Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience [J] . Petrioli Roberto, Francini Edoardo, Roviello Franco, Cancer chemotherapy and pharmacology. . 2015,第5期

机译：晚期胃癌或胃食管癌患者先后使用表柔比星，奥沙利铂和5FU（EOF），多西他赛，奥沙利铂和5FU（DOF）顺序治疗
2. Safety and Efficacy of Neoadjuvant DOF Docetaxel, Oxaliplatin, 5-Fluorouracil Chemotherapy Regimen in Patients with Locally Advanced Gastric and Gastro-Esophageal Junction Cancers: A Single Center Experience from India [J] . Vishal Kulkarni, Satheesh Chiradoni Thungappa, Shekhar Patil, 癌症治疗（英文） . 2020,第005期

机译：新辅助药物DOF 多西他赛，奥沙利铂，5-氟尿嘧啶在局部晚期胃癌和胃食管连接癌患者中的化学治疗方案的安全性和有效性：来自印度的单中心经验
3. Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: Safety and efficacy in a multicenter cohort [J] . PernotS., MitryE., SamalinE., Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2014,第2期

机译：每两周服用多西他赛，氟尿嘧啶，亚叶酸钙，奥沙利铂（TEF）作为晚期胃癌和胃食管交界处腺癌的一线治疗：在多中心队列中的安全性和有效性
4. Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer [C] . K. Sugiyama, A. Ishikawa, T. Watanabe International Gastric Cancer Congress . 2009

机译：组合化疗与多西紫杉醇和伊替康的疗效，作为晚期胃癌的第一或二线治疗
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. Docetaxel oxaliplatin 5FU and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer [O] . Giandomenico Roviello, Roberto Petrioli, Valerio Nardone, -1

机译：多西他赛奥沙利铂5FU和曲妥珠单抗作为人表皮受体2阳性晚期胃或胃食管连接癌患者的一线治疗
7. Safety and Efficacy of Neoadjuvant DOF Docetaxel, Oxaliplatin, 5-Fluorouracil Chemotherapy Regimen in Patients with Locally Advanced Gastric and Gastro-Esophageal Junction Cancers: A Single Center Experience from India [O] . Vishal Kulkarni, Satheesh Chiradoni Thungappa, Shekhar Patil, 2020

机译：Neoadjuvant DOF Docetaxel，Oxaliplatin，5-氟尿嘧啶化疗方案在局部晚期胃和胃食管接合癌患者中的安全性和有效性：印度的单一中心经验

Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience

摘要

著录项

相似文献

相关主题

期刊订阅